Misleading promotion of drugs in Bangladesh: Evidence from drug promotional brochures distributed to general practioners by the pharmaceutical companies

Journal of Public Health

Volumn 29, Issue 2, 2007, Pages 212-213

  Islam, Mohammad Saidul ^a   Farah, Sharmin Shams ^b  

^a Eskayef Bangladesh Limited   (Nepal)

^b School of Pharmacy   (Nepal)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERTIZING; BANGLADESH; DRUG INDUSTRY; ETHICS; GENERAL PRACTITIONER; LETTER; PRESCRIPTION; PROPAGANDA; PUBLICATION;

ADVERTISING AS TOPIC; BANGLADESH; DRUG INDUSTRY; PAMPHLETS; PHYSICIANS, FAMILY; PRESCRIPTIONS, DRUG; PROPAGANDA;

EID: 35348821421     PISSN: 17413842     EISSN: 17413850     Source Type: Journal    
DOI: 10.1093/pubmed/fdm024     Document Type: Letter

References (7)

1. Cardarelli R, Licciardone JC, Taylor LG. A cross-sectional evidence-based review of pharmaceutical promotional marketing brochures and their underlying studies: is what they tell us important and true? BMC Fam Pract 2006;7:13. Available from http://www.biomedcentral.com/1471-2296/7/13 (5 January 2004, date last accessed).
2. Lal A. Pharmaceutical drug promotion: how it is being practiced in India? J Assoc Physicians India 2001; 49:266-73.
3. Islam MS. A review on the policy and practices of therapeutic drug uses in Bangladesh. Calicut Med J 2006; 44:e2.Available from www.calicutmedicaljournal.org/2006/4/4/e2.pdf (2 February 2007, date last accessed).
4. Mansfield PR. Banning all drug promotion is the best option pending major reforms. J. Bioeth Inq 2005;22:75-81.
5. Rohraa DK, Gilania AH, Ismail KM et al. Critical evaluation of the claims made by pharmaceutical companies in drug promotional material in Pakistan. J Pharm Pharmaceut Sci 2006;9(1):50-59.
6. Tuffs A. Only 6% of drug advertising material is supported by evidence. BAJ 2004;328:485.
7. Day M. US study finds data changes in drug companies' brochures. BMJ 2006;332:568